Average Co-Inventor Count = 6.07
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (29 from 3,681 patents)
2. Innate Tumor Immunity, Inc. (2 from 21 patents)
31 patents:
1. 12391675 - NLRP3 modulators
2. 12187706 - NLRP3 modulators
3. 12037323 - Uracil derivatives as Mer-AXL inhibitors
4. 10112941 - Tricyclic compounds as anticancer agents
5. 9751879 - Tricyclic compounds as anticancer agents
6. 9725449 - Tricyclic compounds as anticancer agents
7. 9492460 - Carbazole compounds useful as bromodomain inhibitors
8. 9458156 - Tricyclic compounds as anticancer agents
9. 9382219 - Cyclic protein tyrosine kinase inhibitors
10. 9242941 - Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds
11. 8993567 - Cyclic protein tyrosine kinase inhibitors
12. 8716323 - Cyclic protein tyrosine kinase inhibitors
13. 8067582 - Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
14. 8063208 - Crystalline forms of (3R,4R)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol
15. 7846931 - Pyrrolotriazine compounds as kinase inhibitors